TELA Bio, Inc. (TELA) Free cash flow 2017–2025
TELA Bio, Inc. (TELA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$28.7MFY2025 · since FY2017: -$16.5M → -$28.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$28.7M | +32.7% |
| FY2024 | -$42.6M | -2.7% |
| FY2023 | -$41.5M | +0.4% |
| FY2022 | -$41.6M | -34.0% |
| FY2021 | -$31.1M | -26.1% |
| FY2020 | -$24.6M | +4.3% |
| FY2019 | -$25.7M | -28.7% |
| FY2018 | -$20.0M | -21.3% |
| FY2017 | -$16.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice